|
|
|
40
|
30828
|
PRIVIGEN 10% INJ (CSL/AHI) IMMUNOGLOBULIN
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
100ML
|
BQ
|
1,413.53
|
1,413.53
|
INJECTION
|
0
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2022-05-10
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
2022-03-29
|
|
|
|
41
|
30828
|
PRIVIGEN 10% INJ (CSL) IMMUNOGLOBULIN (BQ)
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
100ML
|
BQ
|
1766.91
|
1766.9106
|
BOTT
|
50
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
41
|
3082A
|
IMMUNOREL 10% INJ (RLS) IMMUNOGLOBU (BQ)
|
IMMUNOGLOBULIN
|
IMMUNOREL
|
100ML
|
BQ
|
1353.73
|
1353.7254
|
VIAL
|
50
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
42
|
3082B
|
IMMUNOGLOBULIN 10% INJ (INP)
|
IMMUNOGLOBULIN HUMAN
|
IMMUNOGLOBULIN
|
50ML VIAL
|
BQ
|
538.83
|
538.83
|
VIAL
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
42
|
3082C
|
NORMOGLOBIN 10% INJ (INC) IMMUNOGLOBULIN HUMAN
|
IMMUNOGLOBULIN HUMAN
|
NORMOGLOBIN
|
50ML VIAL
|
BQ
|
615.86
|
615.86
|
VIAL
|
0
|
VIAL
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
42
|
3082D
|
PRIVIGEN 10% INJ (CSL) HUMAN IMMUNOGLOBULIN
|
HUMAN IMMUNOGLOBULIN
|
PRIVIGEN
|
100ML
|
BQ
|
1,603.81
|
1,603.81
|
VIAL
|
0
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
2028-03-31
|
|
IV/IM/SC
|
0
|
SERUMS
|
2025-11-10
|
|
|
|
40
|
30914
|
TETAGAM 250IU INJ (CSL/AHI) TETANUS ANTITOXIN
|
TETANUS ANTITOXIN
|
TETAGAM
|
1ML AMP
|
B
|
67.96
|
67.96
|
INJECTION
|
0
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
30914
|
TETAGAM 250IU INJ (CSL) TETANUS ANTITOXI
|
TETANUS ANTITOXIN
|
TETAGAM
|
1ML AMP
|
B
|
108.73
|
108.733
|
AMP
|
40
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8012
|
VACCINES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
VACCINES
|
|
|
|
|
42
|
3091J
|
TETAGAM P 250IU/ML PREFIL SYRN (CSL) IMMUNOGLOBULIN HUMAN
|
TETANUS IMMUNOGLOBULIN HUMAN
|
TETAGAM P
|
4X1ML PFS
|
B
|
108.73
|
108.73
|
PFS
|
0
|
PFS
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
2028-03-31
|
|
IM
|
0
|
SERUMS
|
2025-11-10
|
|
|
|
40
|
3101B
|
TETANUS TOXOID (SII/COL)
|
TETANUS TOXOID
|
TETANUS TOXOID
|
10 DS VIAL
|
B
|
25.01
|
25.01
|
INJECTION
|
0
|
VIAL
|
SII
|
SERUM INSTITUTE OF INDIA PRIVATE LTD
|
COL
|
COLLINS LTD
|
|
8008
|
TOXOIDS
|
2022-04-01
|
2024-03-31
|
|
IM
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
3101B
|
TETANUS TOXOID (SII)
|
TETANUS TOXOID
|
TETANUS TOXOID
|
10 DS VIAL
|
B
|
25.01
|
25.0086
|
VIAL
|
40
|
VIAL
|
SII
|
SERUM INSTITUTE OF INDIA PRIVATE LTD
|
COL
|
COLLINS LTD
|
|
8012
|
VACCINES
|
2024-04-01
|
2026-03-31
|
|
IM
|
0
|
VACCINES
|
|
|
|
|
40
|
3151A
|
APO-EZETIMIBE 10MG TAB (APO/COL)
|
EZETIMIBE
|
APO-EZETIMIBE
|
100'S
|
A
|
21.75
|
0.22
|
TABLET
|
30
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
240605
|
CHOLESTEROL ABSORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
3151C
|
EZETROL 10MG TAB (MSD/STO) EZETIMIBE
|
EZETIMIBE
|
EZETROL
|
30'S
|
C
|
47.30
|
1.58
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
240605
|
CHOLESTEROL ABSORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
3151C
|
EZETROL 10MG TAB (MSD) EZETIMIBE (C)
|
EZETIMIBE
|
EZETROL
|
30'S
|
C
|
47.76
|
1.592
|
TAB
|
30
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
240605
|
CHOLESTEROL ABSORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CHOLESTEROL ABSORPTION INHIBITORS
|
|
|
|
|
42
|
3151C
|
EZETROL 10MG TAB (MSD) EZETIMIBE
|
EZETIMIBE
|
EZETROL
|
30'S
|
C
|
47.76
|
1.59
|
TAB
|
30
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
240605
|
CHOLESTEROL ABSORPTION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
CHOLESTEROL ABSORPTION INHIBITORS
|
|
|
|
|
41
|
3151H
|
APO-EZETIMIBE 10MG TAB (APO) EZETIM
|
EZETIMIBE
|
APO-EZETIMIBE
|
100'S
|
A
|
22.18
|
0.2218
|
TAB
|
30
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240605
|
CHOLESTEROL ABSORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CHOLESTEROL ABSORPTION INHIBITORS
|
|
|
|
|
42
|
3151K
|
EZENTIB 10MG TAB (JLP) EZETIMIBE
|
EZETIMIBE
|
EZENTIB
|
10X10
|
A
|
32.62
|
0.33
|
TAB
|
30
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240605
|
CHOLESTEROL ABSORPTION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
CHOLESTEROL ABSORPTION INHIBITORS
|
|
|
|
|
40
|
31712
|
ENBREL 50MG INJ (PFI/STO) ETANERCEPT
|
ETANERCEPT
|
ENBREL
|
4X50MG
|
C
|
2,966.78
|
741.70
|
INJECTION
|
0
|
PFS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
31712
|
ENBREL 50MG INJ (PFI) ETANERCEPT (C)
|
ETANERCEPT
|
ENBREL
|
4X50MG
|
C
|
2995.86
|
748.9662
|
PFS
|
1
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
31712
|
ENBREL 50MG/ML INJ (PFI) ETANERCEP (C)
|
ETANERCEPT
|
ENBREL
|
4X50MG
|
C
|
2,995.87
|
748.97
|
PFS
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
